Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

465
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
465
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

477
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
477
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

246
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
246
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

264
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
264
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

444
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
444
Irritable Bowel Syndrome I: Introduction01:17

Irritable Bowel Syndrome I: Introduction

574
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
574

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effectiveness of electrical stimulation for postoperative rehabilitation of lung cancer: a systematic review and meta-analysis.

Journal of thoracic disease·2026
Same author

Stiffness-dependent CMOT hydrogels promote mucosal repair in ulcerative colitis through YAP‑mediated mechanosensing in intestinal epithelial cells.

Journal of nanobiotechnology·2026
Same author

A nonspecific lipid transfer protein, CtnsLTP18, mediates drought stress resistance in Cynanchum thesioides.

Plant cell reports·2026
Same author

Targeting Maladaptive Memory Circuits in Heroin Addiction: a Review of Non-Pharmacological Interventions for Cognitive Recovery.

Journal of molecular neuroscience : MN·2026
Same author

Liver-related outcomes in patients with tricuspid regurgitation.

European journal of heart failure·2026
Same author

People with chronic obstructive pulmonary disease and exercise behaviour: a scoping review using the CFIR framework.

BMC pulmonary medicine·2026

Related Experiment Video

Updated: Oct 26, 2025

Investigating Intestinal Inflammation in DSS-induced Model of IBD
08:43

Investigating Intestinal Inflammation in DSS-induced Model of IBD

Published on: February 1, 2012

67.9K

Artificial Intelligence Enhances Studies on Inflammatory Bowel Disease.

Guihua Chen1, Jun Shen1

  • 1Division of Gastroenterology and Hepatology, Key Laboratory of Gastroenterology and Hepatology, Ministry of Health, Inflammatory Bowel Disease Research Center, Shanghai Institute of Digestive Disease, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.

Frontiers in Bioengineering and Biotechnology
|July 26, 2021
PubMed
Summary

Artificial intelligence (AI) enhances the diagnosis of inflammatory bowel disease (IBD), including ulcerative colitis and Crohn's disease. AI algorithms improve diagnostic reliability by analyzing medical images and distinguishing key features for earlier intervention.

Keywords:
Crohn’s diseaseartificial intelligenceinflammatory bowel diseasemachine learningulcerative colitis

More Related Videos

Induction of Intestinal Inflammation by Adoptive Transfer of CBir1 TCR Transgenic CD4+ T Cells to Immunodeficient Mice
07:34

Induction of Intestinal Inflammation by Adoptive Transfer of CBir1 TCR Transgenic CD4+ T Cells to Immunodeficient Mice

Published on: December 16, 2021

2.8K
Induction of Murine Intestinal Inflammation by Adoptive Transfer of Effector CD4+CD45RBhigh T Cells into Immunodeficient Mice
08:37

Induction of Murine Intestinal Inflammation by Adoptive Transfer of Effector CD4+CD45RBhigh T Cells into Immunodeficient Mice

Published on: April 21, 2015

17.0K

Related Experiment Videos

Last Updated: Oct 26, 2025

Investigating Intestinal Inflammation in DSS-induced Model of IBD
08:43

Investigating Intestinal Inflammation in DSS-induced Model of IBD

Published on: February 1, 2012

67.9K
Induction of Intestinal Inflammation by Adoptive Transfer of CBir1 TCR Transgenic CD4+ T Cells to Immunodeficient Mice
07:34

Induction of Intestinal Inflammation by Adoptive Transfer of CBir1 TCR Transgenic CD4+ T Cells to Immunodeficient Mice

Published on: December 16, 2021

2.8K
Induction of Murine Intestinal Inflammation by Adoptive Transfer of Effector CD4+CD45RBhigh T Cells into Immunodeficient Mice
08:37

Induction of Murine Intestinal Inflammation by Adoptive Transfer of Effector CD4+CD45RBhigh T Cells into Immunodeficient Mice

Published on: April 21, 2015

17.0K

Area of Science:

  • Gastroenterology and Medical Imaging
  • Computational Biology and Bioinformatics
  • Artificial Intelligence in Medicine

Background:

  • Inflammatory bowel disease (IBD), encompassing ulcerative colitis (UC) and Crohn's disease (CD), is a chronic condition driven by immune dysregulation.
  • IBD affects 84.3 per 100,000 individuals globally, incurring substantial direct and indirect economic costs.
  • Current IBD diagnosis relies on subjective interpretation of lab tests and medical imaging, hindering early detection and intervention.

Purpose of the Study:

  • To summarize the application of artificial intelligence (AI) in diagnosing and predicting outcomes for IBD.
  • To objectively evaluate the performance of various AI methods in the context of IBD.
  • To understand the optimal combination of AI algorithms and datasets for IBD research.

Main Methods:

  • Utilized support vector machines (SVMs) to identify significant features for IBD diagnosis.
  • Employed convolutional neural networks (CNNs), advanced image processing algorithms, for lesion detection and classification in digestive endoscopic images.
  • Reviewed and analyzed existing studies on AI applications in IBD.

Main Results:

  • SVMs demonstrated improved diagnostic reliability for IBD through effective classification and regional analysis.
  • CNNs offer enhanced understanding of digestive endoscopic images by automating lesion detection and classification.
  • The study provides insights into the performance of different AI-algorithm-dataset combinations for IBD.

Conclusions:

  • AI-assisted diagnostic tools show significant promise for improving the accuracy and efficiency of IBD detection.
  • Automated analysis of endoscopic images using AI can aid clinicians in identifying subtle lesions.
  • Further research into AI-dataset combinations is crucial for optimizing IBD management and patient outcomes.